1. Home
  2. PSTV vs GROV Comparison

PSTV vs GROV Comparison

Compare PSTV & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • GROV
  • Stock Information
  • Founded
  • PSTV 1996
  • GROV 2016
  • Country
  • PSTV United States
  • GROV United States
  • Employees
  • PSTV N/A
  • GROV N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • GROV Package Goods/Cosmetics
  • Sector
  • PSTV Health Care
  • GROV Consumer Discretionary
  • Exchange
  • PSTV Nasdaq
  • GROV Nasdaq
  • Market Cap
  • PSTV 61.1M
  • GROV 64.0M
  • IPO Year
  • PSTV N/A
  • GROV N/A
  • Fundamental
  • Price
  • PSTV $0.51
  • GROV $1.25
  • Analyst Decision
  • PSTV Strong Buy
  • GROV Buy
  • Analyst Count
  • PSTV 4
  • GROV 2
  • Target Price
  • PSTV $7.75
  • GROV $1.35
  • AVG Volume (30 Days)
  • PSTV 9.7M
  • GROV 98.8K
  • Earning Date
  • PSTV 10-30-2025
  • GROV 11-13-2025
  • Dividend Yield
  • PSTV N/A
  • GROV N/A
  • EPS Growth
  • PSTV N/A
  • GROV N/A
  • EPS
  • PSTV N/A
  • GROV N/A
  • Revenue
  • PSTV $5,258,000.00
  • GROV $185,354,000.00
  • Revenue This Year
  • PSTV $9.91
  • GROV N/A
  • Revenue Next Year
  • PSTV $1.06
  • GROV $11.10
  • P/E Ratio
  • PSTV N/A
  • GROV N/A
  • Revenue Growth
  • PSTV N/A
  • GROV N/A
  • 52 Week Low
  • PSTV $0.16
  • GROV $1.02
  • 52 Week High
  • PSTV $2.31
  • GROV $1.95
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 40.47
  • GROV 35.14
  • Support Level
  • PSTV $0.49
  • GROV $1.26
  • Resistance Level
  • PSTV $0.55
  • GROV $1.39
  • Average True Range (ATR)
  • PSTV 0.05
  • GROV 0.10
  • MACD
  • PSTV -0.02
  • GROV -0.02
  • Stochastic Oscillator
  • PSTV 10.97
  • GROV 25.00

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: